Sign In
Buy LH
$258.92
+1.22 (+0.473%)
At Close: Jun 03, 2026
LabCorp (LH) Base Business Growth Strong, Margin Pressure Stays
12:11pm, Tuesday, 16'th May 2023
LabCorp (LH) is progressing well with its planned spin-off of the Clinical Development business, which is expected to be completed in mid-2023.
Laboratory Corporation of America Holdings (LH) Q1 2023 Earnings Call Transcript
03:56pm, Tuesday, 25'th Apr 2023
Laboratory Corporation of America Holdings (LH) Q1 2023 Earnings Call Transcript.
LabCorp (LH) Q1 Earnings Miss Estimates, Margins Decline
01:40pm, Tuesday, 25'th Apr 2023
The decline in COVID-19 PCR and antibody testing sales, the severe foreign exchange headwind and inflationary pressure hurt LabCorp's (LH) business performance in Q1.
LabCorp (LH) Misses Q1 Earnings Estimates
09:09am, Tuesday, 25'th Apr 2023
LabCorp (LH) came out with quarterly earnings of $3.82 per share, missing the Zacks Consensus Estimate of $3.99 per share. This compares to earnings of $6.11 per share a year ago.
7 Low-PE Ratio Blue-Chip Stocks Offering Both Quality and Value
07:32pm, Wednesday, 19'th Apr 2023
While the concept of acquiring low-PE ratio blue-chip stocks (that is, industry-leading stalwarts that feature low price-earnings ratios relative to their sectors) appeals on paper, investors need to
8 Defensive Plays as Healthcare Stocks Stumble
11:13am, Wednesday, 19'th Apr 2023
Healthcare stocks have sputtered this year after performing well in 2022. A Barron's screen has identified stocks that are poised to outperform for the rest of the year.
LabCorp (LH) Expands Colon Cancer Test Access With New Pact
01:42pm, Tuesday, 04'th Apr 2023
LabCorp's (LH) at-home collection kit will offer patients an additional and easier option to get screened for colon cancer.
Labcorp to pay $2.1 million to settle allegations it overbilled Defense Department for genetic tests for military members
03:08pm, Monday, 27'th Mar 2023
A former Labcorp employee turned whistleblower sued the diagnostic testing company in 2018 on behalf of the federal government under the False Claims Act.
Here's Why Investors Should Retain LabCorp (LH) Stock for Now
02:30pm, Tuesday, 14'th Mar 2023
Investors are optimistic about LabCorp (LH) backed by strength in its Drug Development business.
LabCorp (LH) Focuses on High-Growth Areas Amid Currency Woe
12:02pm, Wednesday, 08'th Mar 2023
In its efforts to expand further, LabCorp (LH) is focusing more on high-growth opportunity areas such as neurodegenerative, autoimmune and liver disease as well as cell and gene therapy.
Laboratory Corporation of America Holdings (LH) Q4 2022 Earnings Call Transcript
03:56pm, Thursday, 16'th Feb 2023
Laboratory Corporation of America Holdings (NYSE:LH ) Q4 2022 Earnings Conference Call February 16, 2023 9:00 AM ET Company Participants Chas Cook - Vice President of Investor Relations Adam Schechter
LabCorp (LH) Q4 Earnings Surpass Estimates, Margins Fall
12:02pm, Thursday, 16'th Feb 2023
The severe foreign exchange headwind, inflationary pressure and the ongoing Ukraine/Russia crisis impact LabCorp's (LH) business performance in Q4.
LabCorp reports 20% drop in COVID test sales in Q4
08:00am, Thursday, 16'th Feb 2023
Shares of Labcorp LH, +1.79% were down about 2.9% in premarket trading on Thursday after the diagnostics company reported lower-than-expected revenue in the fourth quarter of 2022. Labcorp had earning
Labcorp to spin off its clinical research organization under the name Fortrea
07:42am, Thursday, 09'th Feb 2023
Labcorp LH, -0.52% said Thursday that it plans to spin off its clinical development business into a publicly traded clinical research organization, or CRO, in mid-2023. The name of the planned spin-of
LabCorp's (LH) New Launches, Planned Spinoff to Aid Growth
01:33pm, Monday, 06'th Feb 2023
In terms of portfolio enhancement, LabCorp (LH) enters into a collaboration with Becton, Dickinson and Company to advance in life-changing treatments for cancer and other diseases.
